Martha Ladner

Title: Martha Ladner: Innovator in Genetic Research

Introduction

Martha Ladner is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of genetic research, particularly in the determination of KIR haplotypes associated with disease. With a total of 2 patents, her work has advanced our understanding of genetic variations and their implications for health.

Latest Patents

Martha Ladner's latest patents focus on innovative methods for determining KIR genotypes. One of her patents discloses a method that involves amplifying the polymorphic exon sequences of KIR genes for one or more individuals in parallel. This method includes pooling the KIR amplicons and performing emulsion PCR followed by pyrosequencing to determine all the amplicon sequences present in the individual. This groundbreaking approach allows for the identification of which KIR alleles are present in each individual, providing valuable insights into genetic predispositions to diseases.

Career Highlights

Throughout her career, Martha has worked with notable organizations such as Roche Molecular Systems, Inc. and Children's Hospital & Research Center at Oakland. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in genetic research.

Collaborations

Martha has collaborated with esteemed colleagues, including Elizabeth A Trachtenberg and Lloyd Gordon Bentley. These partnerships have enriched her research and expanded the impact of her innovations in the scientific community.

Conclusion

Martha Ladner's contributions to genetic research through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in understanding genetic diseases and their implications for health.